Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
6
3
0
0
INOZYME PHARMA INC Share · US45790W1080 · INZY (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of INOZYME PHARMA INC
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float 67,18 %
Shares Float 43,37 M
Shares Outstanding 64,56 M
Invested Funds
The following funds have invested in INOZYME PHARMA INC:
Fund | Vol. in million 11,68 | Percentage (%) 0,03 % |
Company Profile for INOZYME PHARMA INC Share
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Company Data
Name INOZYME PHARMA INC
Company Inozyme Pharma, Inc.
Symbol INZY
Website
https://www.inozyme.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US45790W1080
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Douglas A. Treco
Market Capitalization 258 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 321 Summer Street, 02210 Boston
IPO Date 2020-07-24
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | INZY |
More Shares
Investors who hold INOZYME PHARMA INC also have the following shares in their portfolio:
